Trends of copper deficiency following one anastomosis gastric bypass and Roux-en-Y gastric bypass.

The Hidden Cost of Rapid Weight Loss

Metabolic and bariatric surgery (MBS) is the most effective intervention for treating severe obesity. However, these procedures introduce long-term risks regarding micronutrient deficiencies. One such deficiency involves copper. Copper is an essential trace element. It is required for hematopoiesis (the production of blood cells), connective tissue formation, and nervous system function. Copper deficiency can cause non-specific symptoms like fatigue or gait instability. This often leads to underdiagnosis. If not caught early, it can cause irreversible neurological injury.

Clinicians recognize that Roux-en-Y gastric bypass (RYGB) and one-anastomosis gastric bypass (OAGB) both pose risks for copper depletion. Both procedures cause malabsorption (the reduced absorption of nutrients). They achieve this by bypassing the primary sites of copper uptake in the digestive tract. Yet, direct comparative evidence is limited. This study compares copper deficiency trends between these two procedures. It also identifies which patient characteristics predict a drop in serum copper levels.

The Malabsorptive Gap in Bariatric Care

The central problem in post-bariatric nutrition is the mechanism of weight loss. Altering anatomy to limit calories also disrupts mineral uptake. Copper deficiency arises from two main drivers. First, the procedures bypass the duodenum and proximal jejunum. These are the critical zones for mineral absorption. Second, excess zinc intake causes biological interference. High zinc levels induce metallothionein (a protein that binds metals) in intestinal cells. This protein sequesters copper. This process prevents copper from entering the bloodstream.

Until now, clinicians have lacked clear comparative data. Some literature suggests OAGB carries a higher malabsorptive burden. However, much of the existing evidence relies on isolated case reports. Large-scale comparative cohorts are rare. Practitioners currently rely on generic supplementation protocols. These protocols often fail a significant subset of patients.

Tracking Copper Declines Post-Surgery

The authors conducted a retrospective cohort study of 294 adults. These patients underwent either RYGB or OAGB between 2020 and 2022. Researchers measured serum copper levels at three stages. These were baseline (preoperatively), 6 months, and 12 months postoperatively. The study defines copper deficiency as a serum copper level below 75 µg/dL.

The methodology isolated the influence of surgery from other variables. The researchers tracked several key indicators: 1. Hematologic Indices: They monitored hemoglobin and mean corpuscular volume (MCV, a measure of red blood cell size) to detect anemia. 2. Nutrient Competition: They recorded serum zinc levels to account for competitive absorption. 3. Iron Stores: They measured ferritin (a protein that stores iron) to differentiate copper deficiency from iron deficiency.

The study used multivariable logistic regression (a statistical method to find relationships between multiple variables). This helped determine if surgery type, age, or weight loss rate predicted deficiency.

Comparable Risks and Predictors of Deficiency

The results show that surgical architecture is not the deciding factor. The prevalence of copper deficiency through 12 months was comparable between OAGB and RYGB. No statistically significant differences were observed between the two procedures [Table 5]. However, a universal trend emerged. Mean serum copper levels declined significantly in both groups by the 6-month mark. Levels remained below baseline at 12 months .

The most striking finding concerns specific risk factors. Female sex and greater 6-month total weight loss (%TWL) were independent predictors of deficiency. The authors report an odds ratio of 1.12 for 6-month %TWL. This means every unit increase in weight loss percentage raises the likelihood of deficiency.

Researchers used receiver operating characteristic (ROC) analysis to find a predictive threshold. This analysis helps determine how well a test predicts an outcome. The study suggests a 6-month %TWL of approximately 29% is the optimal cutoff . Patients exceeding this threshold are at higher risk. Notably, the authors found no significant links between copper status and age or procedure type.

Limitations of the Observational Data

The study is constrained by its retrospective, single-center design. This limits the ability to apply results to all populations. Several technical limitations exist: * Biomarker Specificity: Classification relied solely on serum copper. The authors did not routinely measure ceruloplasmin (the primary copper-carrying protein). This could limit the nuance of the findings. * Adherence Uncertainty: Researchers could not objectively verify supplement use. This introduces the possibility of exposure misclassification. A deficiency might stem from poor compliance rather than surgery. * Statistical Power: The number of deficiency events was low. This made multivariable adjustments for certain factors exploratory rather than definitive.

The Verdict: Targeted Surveillance is Mandatory

The evidence suggests copper deficiency is a shared risk for all gastric bypass procedures. It is not unique to one specific technique. Because mean copper levels drop universally within the first year, clinicians must act.

Monitoring should be proactive rather than reactive. The 29% weight loss threshold at 6 months provides an actionable metric. Practitioners should implement targeted biochemical surveillance during the first 12 months. This is especially vital for patients experiencing rapid weight loss. Standard supplementation may be insufficient to counter malabsorption and rapid metabolic shifts.

Figures from the paper